Length of warm ischemic tolerance for epithelial regeneration in heterotopic rat tracheal isog-rafts
2011-08-15HanJingquan韩敬泉DeptThoracSurg4thAffilHospHarbinMedUnivHarbin150001ChinTransplant201132430432
Han Jingquan(韩敬泉,Dept Thorac Surg,4th Affil Hosp Harbin Med Univ,Harbin 150001)…∥Chin J Transplant.-2011,32(7).-430 ~432
Length of warm ischemic tolerance for epithelial regeneration in heterotopic rat tracheal isog-rafts
Han Jingquan(韩敬泉,Dept Thorac Surg,4th Affil Hosp Harbin Med Univ,Harbin 150001)…∥Chin J Transplant.-2011,32(7).-430 ~432
ObjectiveTo determine the length of warm ischemic(WI)tolerance in bronchial graft from non-heart- beating donors.MethodsForty - eight rats were randomly divided into 4 groups(each group having 12 rats)according to different WI durations including WI-0 min(group A),WI-30 min(group B),WI-45 min(group C)and WI-60 min(group D).In each group,the tracheae from 6 rats were respectively imbedded in greater omentum of other 6 rats,and 14 days later,the transplanted tracheae were taken from recipients to evaluate epithelial thickness and regeneration.ResultsEpithelial thickness and the degree of epithelial regeneration had no significant difference P >0.05 between the syngeneic control group and the WI-30 minutes group.All of the grafts with WI duration of 45 min were viable,but the epithelium was significantly thinner than that in the syngeneic control group P < 0.05.However all of the grafts with WI duration of 60 min showed lower viability rate.ConclusionThe time limits of tolerance to WI of tracheal grafts from NHBDs may be 45 min.8 refs,2 figs,1 tab.
(Authors)
杂志排行
外科研究与新技术的其它文章
- Expression of bradykinin as a substrate of CD26/DPP IV in rats ischemia/reperfusion injury following lung transplantation
- Apoptosis and oxidative injury of donor islets during isolatio
- Efficacy of rituximab-containing regimens on post-transplantation lymphoproliferative disorder following haploidentical hematopoietic stem cell trans-plantatio: reor f 3 css
- Ailogeneic hematopoietic cell transplantation for malignant hematological diseases in patients older than 50 yers of g
- Clinical analysis of 100 cases of lung transplantation for end-stage palmonary disease
- Combined intensive preconditioning regimen allo-HSCT with imatinib for treatment of Ph chromosome positive acute lymphocyte leukemia
